MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene

被引:29
作者
Alderman, Christopher [1 ]
Sehlaoui, Ayoub [1 ]
Xiao, Zhaoyang [2 ]
Yang, Yixin [1 ]
机构
[1] Emporia State Univ, Dept Biol Sci, 1 Kellogg Circle, Emporia, KS 66801 USA
[2] Dalian Med Univ, Affiliated Hosp 2, Dept Emergency Med, 467 Zhongshan Rd, Dalian, Peoples R China
基金
美国国家卫生研究院; 中国国家自然科学基金;
关键词
miR-15a; Melanoma; CDCA4; AKT3; Cell cycle; Invasion; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; IMPROVED SURVIVAL; MESSENGER-RNAS; CANCER; EXPRESSION; APOPTOSIS; MIR-15A; PROGRESSION; METASTASIS;
D O I
10.1007/s13277-016-5271-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs can affect behaviors of tumor cells by modulating the expression of the target genes that involve tumor growth, invasiveness, and death. The goal of this research is to examine the effects of miR-15a on the proliferation and invasiveness of malignant melanoma cells in vitro, as well as the therapeutic effect of miR-15a in a mouse melanoma model. miR-15a displayed inhibitory effects on proliferation and invasiveness of several malignant melanoma cell lines. miR-15a also caused cell cycle arrest at G1/G0 phase. miRNA 15a downregulated the expressions of CDCA4 and AKT-3 in melanoma cell lines. In vivo, experiment showed that miRNA 15a significantly retarded the growth of melanoma tumors in the mouse model. The luciferase reporter assay demonstrated that miR15a can suppress gene expression through the binding site in the 3 'UTR of CACD4, which is a bona fide target of miRNA 15a. In conclusion, miRNA 15a suppressed the growth and invasiveness of melanoma cells, suggesting that miRNA 15a may represent a viable microRNA-based therapy against melanoma.
引用
收藏
页码:13941 / 13950
页数:10
相关论文
共 47 条
[1]   The three M's: melanoma, microphthalmia-associated transcription factor and microRNA [J].
Bell, Rachel E. ;
Levy, Carmit .
PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (06) :1088-1106
[2]   MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines [J].
Bemis, Lynne T. ;
Chen, Robert ;
Amato, Carol M. ;
Classen, Elizabeth H. ;
Robinson, Steven E. ;
Coffey, David G. ;
Erickson, Paul F. ;
Shellman, Yiqun G. ;
Robinson, William A. .
CANCER RESEARCH, 2008, 68 (05) :1362-1368
[3]   miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma [J].
Bennett, Paige E. ;
Bemis, Lynne ;
Norris, David A. ;
Shellman, Yiqun G. .
PHYSIOLOGICAL GENOMICS, 2013, 45 (22) :1049-1059
[4]   MicroRNA regulation of melanoma progression [J].
Bonazzi, Vanessa F. ;
Stark, Mitchell S. ;
Hayward, Nicholas K. .
MELANOMA RESEARCH, 2012, 22 (02) :101-113
[5]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[6]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[7]   Akt and mutant V600EB-Raf cooperate to promote early melanoma development [J].
Cheung, Mitchefl ;
Sharma, Arati ;
Madhunapantula, SubbaRao V. ;
Robertson, Gavin P. .
CANCER RESEARCH, 2008, 68 (09) :3429-3439
[8]   miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein [J].
Dar, Altaf A. ;
Majid, Shahana ;
de Semir, David ;
Nosrati, Mehdi ;
Bezrookove, Vladimir ;
Kashani-Sabet, Mohammed .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (19) :16606-16614
[9]   The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms [J].
Felicetti, Federica ;
Errico, M. Cristina ;
Bottero, Lisabianca ;
Segnalini, Patrizia ;
Stoppacciaro, Antonella ;
Biffoni, Mauro ;
Felli, Nadia ;
Mattia, Gianfranco ;
Petrini, Marina ;
Colombo, Mario P. ;
Peschle, Cesare ;
Care, Alessandra .
CANCER RESEARCH, 2008, 68 (08) :2745-2754
[10]   Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma [J].
Flaherty, Keith T. ;
Robert, Caroline ;
Hersey, Peter ;
Nathan, Paul ;
Garbe, Claus ;
Milhem, Mohammed ;
Demidov, Lev V. ;
Hassel, Jessica C. ;
Rutkowski, Piotr ;
Mohr, Peter ;
Dummer, Reinhard ;
Trefzer, Uwe ;
Larkin, James M. G. ;
Utikal, Jochen ;
Dreno, Brigitte ;
Nyakas, Marta ;
Middleton, Mark R. ;
Becker, Juergen C. ;
Casey, Michelle ;
Sherman, Laurie J. ;
Wu, Frank S. ;
Ouellet, Daniele ;
Martin, Anne-Marie ;
Patel, Kiran ;
Schadendorf, Dirk .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :107-114